Bill > HR7535

This bill requires the Comptroller General of the United States to conduct a study and submit a report on price-related compensation and payment structures in the prescription drug supply chain. The study will provide an overview of the types, magnitudes, and prevalence of compensation and payment structures related to a prescription drug's price between various entities in the supply chain, such as pharmacy benefit managers, plan sponsors, wholesalers, pharmacies, and manufacturers. It will also examine the primary business models and compensation structures for each category of intermediary, variations in price-related compensation structures between affiliated and unaffiliated entities, potential conflicts of interest, and trends in price-based compensation structures over time and between different market segments. The Comptroller General will then provide recommendations for any appropriate legislative or administrative action based on the findings of the study.

Business and Industry, Health and Social Services

https://www.congress.gov/bill/118th-congress/house-bill/7535/all-info